Biochemical Characterization of Individual Human Glycosylated pro-Insulin-like Growth Factor (IGF)-II and big-IGF-II Isoforms Associated with Cancer
Open Access
- 4 January 2013
- journal article
- Published by Elsevier BV
- Vol. 288 (1), 59-68
- https://doi.org/10.1074/jbc.m112.432013
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Phospholipase C and Protein Kinase C-β 2 Mediate Insulin-Like Growth Factor II-Dependent Sphingosine Kinase 1 ActivationMolecular Endocrinology, 2011
- Plasma Distribution and Signaling Activities of IGF-II PrecursorsEndocrinology, 2011
- Cushing's syndrome and big IGF-II associated hypoglycaemia in a patient with adrenocortical carcinomaBMJ Case Reports, 2010
- IGF2: Epigenetic regulation and role in development and diseaseCytokine & Growth Factor Reviews, 2008
- Precursor Igf-ii (Proigf-ii) And Mature Igf-ii (Migf-ii) Induce Bcl-2 And Bcl-xlExpression Through Different Signaling Pathways In Breast Cancer CellsGrowth Factors, 2008
- Structure and functional analysis of the IGF-II/IGF2R interactionThe EMBO Journal, 2007
- Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailabilityBiochemical and Biophysical Research Communications, 2005
- Secretion of Noncomplexed ‘Big’ (10–18 kD) Forms of Insulin-Like Growth Factor-II by 12 Soft Tissue Sarcoma Cell LinesHormone Research in Paediatrics, 1999
- Crystallization of the first three domains of the human insulin‐like growth factor‐1 receptorProtein Science, 1997
- Biophysical and Biological Properties of Naturally Occurring High Molecular Weight Insulin-like Growth Factor II VariantsPublished by Elsevier BV ,1997